Guarneri V, Dieci MV, Bisagni G, Brandes AA, et al. PIK3CA mutation in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer: association with prognosis and integration with PAM50 subtype. Clin Cancer Res 2020 Aug 25. pii: 1078-0432.CCR-20-1731.
PMID: 32843527